CRT 2025

Panel Discussion | Future of Renal Denervation Studies and Clinical Implementation

Panel Moderator(s)

• 

  Herbert D. Aronow, MD, MPH

  Medical Director, Heart & Vascular Services
  Henry Ford Health
  Detroit, Michigan, United States

  Disclosure(s): Amplitude Vascular Systems: Consultant (Ongoing); Medtronic: Consultant (Ongoing); Novartis Pharmaceuticals: Consultant (Terminated); Rapid AI: Consultant (Ongoing)
• 

  Justin E. Davies, MD, PhD

  Cardiologist
  Imperial College London
  London, England, United Kingdom

  Disclosure information not submitted.
• 

  Timir Paul, MD, PhD, FACC, FSCAI

  Professor of Medicine; Program Director, Cardiovascular Disease Fellowship
  University of Tennessee Health Science Center- Nashville, Ascension St. Thomas Hospital
  Brentwood, Tennessee, United States

  Disclosure(s): No financial relationships to disclose

Panel Discussant(s)

• 

  Michael J. Bloch, MD

  Medical Director, Vascular Care
  Renown Institute for Heart and Vascular Health
  reno, Nevada, United States

  Disclosure(s): Amgen: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); baralogics: Consulting Fees (e.g., advisory boards) (Ongoing); corcept: Consulting Fees (e.g., advisory boards) (Ongoing); esperion: Consulting Fees (e.g., advisory boards) (Ongoing); idorsia pharmaceuticals: Consulting Fees (e.g., advisory boards) (Ongoing); janssen: Consulting Fees (e.g., advisory boards) (Ongoing); medtronic.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Novartis Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Ongoing); Recor Medical, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); SoniVie: Grant/Research Support (Ongoing)
• 

  Chandan M. Devireddy, MD

  Professor
  Emory University
  Emory University
  Atlanta, Georgia, United States

  Disclosure(s): Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Recor Medical, Inc.: Consultant (Ongoing)
• 

  Dmitriy N. Feldman, FACC, FSCAI, FSVM

  Professor of Medicine
  Weill Cornell Medical College, New York Presbyterian Hospital
  New York, New York, United States

  Disclosure(s): No financial relationships to disclose
• JF

  Jason Fontana, PhD

  Vice President Marketing and Strategy
  Medtronic, California, United States

  Disclosure information not submitted.
• 

  James Stephen Jenkins, MD

  Section Head, Interventional Cardiology Director, Interventional Cardiology Research
  Ochsner Medical Center
  New Orleans, Louisiana, United States

  Disclosure(s): Abbott Labs: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
• 

  Jie Wang, MD, PhD

  Professor
  Jiangsu Province Hospital
  Nanjing, Jiangsu, China (People's Republic)

  Disclosure information not submitted.
• 

  Judith Veis, MD

  Section Director, Nephrology
  Medstar Washington Hospital Center
  Washington, District of Columbia, United States

  Disclosure information not submitted.
• 

  James P. Zidar, MD, FSCAI

  Clinical Professor of Medicine
  University of North Carolina/Rex Healthcare
  Raleigh, North Carolina, United States

  Disclosure(s): CONTEGO MEDICAL: Consulting Fees (e.g., advisory boards) (Ongoing)